SGMO icon

Sangamo Therapeutics
SGMO

Overview Fund Activity

203 hedge funds and large institutions have $994M invested in Sangamo Therapeutics in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 65 increasing their positions, 72 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
203
Holders Change
-19
Holders Change %
-8.56%
% of All Funds
3.57%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
65
Reduced
72
Closed
38
Calls
$18.7M
Puts
$12M
Net Calls
+$6.66M
Net Calls Change
-$11.5M

Top Buyers

1
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$35.8M
2
LOAMS
Lombard Odier Asset Management (Switzerland)
Switzerland
$10.6M
3
CLOS
Compagnie Lombard Odier SCmA
Switzerland
$10.8M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
$8.52M
5
Vanguard Group
Vanguard Group
Pennsylvania
$114M

Top Sellers

1
UBS AM
UBS AM
Illinois
$1.27M
2
Voloridge Investment Management
Voloridge Investment Management
Florida
$0
3
Goldman Sachs
Goldman Sachs
New York
$24.2M
4
CC
Casdin Capital
New York
$6.89M
5
Renaissance Technologies
Renaissance Technologies
New York
$9.77M
Name Holding Trade Value Shares
Change 		Shares
Change %
CC
226
Cannell & Co
New York
– -$159K -10,200 Closed
PWPS
227
Pinnacle Wealth Planning Services
Ohio
– -$80K -5,168 Closed
FMT
228
First Mercantile Trust
Tennessee
– -$56K -3,581 Closed
CWM
229
Cranbrook Wealth Management
Michigan
– -$25K -1,620 Closed
TI
230
tru Independence
Oregon
– -$21.8K -1,400 Closed
ICP
231
Interchange Capital Partners
Pennsylvania
– -$20K -1,300 Closed
RE
232
RBC Europe
United Kingdom
– -$15.6K -1,000 Closed
PS
233
Planned Solutions
California
– -$5K -300 Closed
ASN
234
Advisory Services Network
Georgia
– -$3K -200 Closed
FQ
235
First Quadrant
California
– -$2K -146 Closed
RWA
236
Ropes Wealth Advisors
Massachusetts
– -$1K -70 Closed
6 7 8 9
10